Our Pricing

Cheapest Place To Buy Wegovy UK: Price Comparison & Availability Guide

Finding the cheapest place to buy Wegovy UK can save you hundreds of pounds over the course of your weight loss journey. At Cured Pharmacy, Wegovy is available from £79.00 per pen with transparent upfront pricing, free clinical consultation under 3 minutes, and guaranteed UK stock availability—no hidden fees, no surprise charges at checkout.

Why Wegovy Prices Vary Across UK Pharmacies

Wegovy (semaglutide) pricing varies significantly between UK online pharmacies due to differences in consultation fees, dispensing charges, and delivery costs. Some pharmacies advertise low headline prices but add consultation fees of £79.00-£79.00 at checkout, whilst others bundle all costs upfront. At Cured Pharmacy, our £79.00 starting price includes your clinical assessment by a UK-registered prescriber, with no hidden consultation charges.

Availability also affects pricing. Since Novo Nordisk's manufacturing ramp-up in late 2024, UK supply has stabilised, but not all pharmacies maintain consistent stock across all dose strengths [1]. We guarantee stock availability for all Wegovy doses and display real-time availability before you complete your free consultation, so you're never left waiting weeks for your prescription.

How Wegovy Works for Weight Loss

Wegovy is administered as a once-weekly subcutaneous injection using a pre-filled pen device. Treatment begins at 0.25mg weekly and gradually escalates over 16-20 weeks to the maintenance dose of 2.4mg, allowing your body to adjust and minimising gastrointestinal side effects [3]. This dose escalation schedule is critical for tolerability and is supervised by your UK prescriber throughout your treatment journey.

The Science Behind Semaglutide

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural gut hormone called glucagon-like peptide-1. This hormone regulates appetite by acting on receptors in the brain's hypothalamus, reducing hunger signals and increasing feelings of fullness after meals [2]. Unlike older appetite suppressants, semaglutide works with your body's existing metabolic pathways rather than stimulating the central nervous system.

In the landmark STEP 1 clinical trial, adults using Wegovy 2.4mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [2]. Importantly, 83.5% of participants maintained at least 5% weight loss—the threshold associated with significant cardiometabolic health improvements—demonstrating both efficacy and sustainability when combined with lifestyle modifications.

Wegovy Dosing Schedule and What to Expect

Your Wegovy treatment follows a structured dose escalation protocol approved by the MHRA. You'll start at 0.25mg once weekly for 4 weeks, then increase to 0.5mg for 4 weeks, followed by 1mg, 1.7mg, and finally the maintenance dose of 2.4mg [3]. Each pen is colour-coded and clearly labelled to prevent dosing errors, and our pharmacist team provides full injection technique guidance with your first prescription.

Most patients begin noticing appetite reduction within the first 2-4 weeks, even at the lower starter doses. Weight loss typically becomes noticeable around weeks 8-12, with the most significant changes occurring once you reach the 1.7mg and 2.4mg maintenance doses [2]. Clinical trials showed that weight loss continues progressively for up to 68 weeks, with the majority of reduction occurring in the first 40-50 weeks of treatment.

It's essential to continue treatment as prescribed even during dose escalation. Stopping and restarting Wegovy requires repeating the entire escalation schedule from 0.25mg, which delays your progress and increases the risk of side effects. If you miss a dose by more than 5 days, contact your prescriber before administering your next injection, as you may need to adjust your schedule to maintain tolerability.

Cheapest Place to Buy Wegovy UK: What Affects the Total Cost

Delivery costs and speed also vary. Express or next-day delivery often carries surcharges of £79.00-£79.00 whilst standard tracked delivery may take 3-5 working days. We offer discreet, tracked delivery as standard with no additional charge, and next-day options are available for urgent prescriptions. All orders are dispatched in plain, unbranded packaging to protect your privacy—a critical consideration for many patients using weight management medications.

Hidden Costs to Watch For

When comparing Wegovy prices across UK pharmacies, the advertised pen price is only part of your total cost. Many online pharmacies charge separate consultation fees (typically £79.00-£79.00), prescription processing fees, or delivery charges that only appear at checkout. At Cured Pharmacy, our transparent pricing model means the price you see is the price you pay—consultation, prescription, and standard delivery are all included in our £79.00 starting price.

Another cost factor is prescription frequency. Some pharmacies require monthly consultations with repeat fees, whilst others approve 3-month or 6-month prescriptions after initial assessment. Our UK clinical team can approve extended prescriptions for established patients, reducing the number of consultations needed and lowering your long-term treatment cost. This approach is particularly valuable given that Wegovy is typically prescribed for 12-24 months to achieve and maintain optimal weight loss outcomes.

Who Can Use Wegovy: Eligibility Criteria in the UK

Wegovy is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. NICE guidance also supports its use in these populations when lifestyle interventions alone have been insufficient to achieve clinically meaningful weight loss.

Your UK prescriber will assess your medical history, current medications, and weight loss goals during your free online consultation. Wegovy is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease [3]. It's also not recommended during pregnancy or breastfeeding, and caution is required in patients with diabetic retinopathy or renal impairment.

Treatment is most effective when combined with a reduced-calorie diet and increased physical activity. Clinical trials enrolled patients who received lifestyle counselling alongside Wegovy, and this integrated approach produced the 14.9% average weight reduction seen in STEP 1 [2]. Your prescriber may recommend reviewing your progress at 3-6 month intervals to ensure you're achieving at least 5% weight loss—the threshold for continuing prescription under NICE guidelines.

Common Side Effects and How to Manage Them

Less common but more serious side effects include pancreatitis (inflammation of the pancreas), gallbladder problems, and changes in heart rate [3]. Seek immediate medical attention if you experience severe abdominal pain radiating to your back, persistent vomiting, or signs of allergic reaction such as facial swelling or difficulty breathing. While these events are rare, occurring in less than 2% of trial participants, they require prompt clinical evaluation.

Hypoglycaemia (low blood sugar) is uncommon with Wegovy alone but can occur if you're also taking other diabetes medications such as insulin or sulphonylureas. Symptoms include shakiness, sweating, confusion, and rapid heartbeat. Your prescriber will review your diabetes medications during consultation and may adjust doses to reduce this risk. Always inform your prescriber of all medications and supplements you're currently taking, as drug interactions can affect both efficacy and safety.

Gastrointestinal Effects

The most frequently reported side effects of Wegovy are gastrointestinal: nausea (44% of patients in trials), diarrhoea (30%), vomiting (24%), and constipation (24%) [2]. These effects are typically mild to moderate, occur most commonly during dose escalation, and diminish as your body adjusts to the medication. Eating smaller, more frequent meals and avoiding high-fat foods can significantly reduce nausea intensity.

If nausea persists or becomes severe, contact your prescriber before your next dose increase. In some cases, remaining at your current dose for an additional week or two allows better tolerance before escalating further. Staying well-hydrated is essential, particularly if you experience vomiting or diarrhoea, to prevent dehydration and electrolyte imbalance.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg solution for injection in pre-filled pen - Summary of Product Characteristics. GOV.UK. https://products.mhra.gov.uk/
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity. Technology appraisal guidance [TA875]. NICE. https://www.nice.org.uk/guidance/ta875
4. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and individual results may vary. Side effects can occur—read the patient information leaflet carefully and report any concerns to your prescriber or pharmacist.